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ARTICLE
Self-assembling dipeptide antibacterial
nanostructures with membrane disrupting activity
Lee Schnaider1, Sayanti Brahmachari1, Nathan W. Schmidt2, Bruk Mensa2, Shira Shaham-Niv1, Darya Bychenko1,
Lihi Adler-Abramovich3, Linda J.W. Shimon 4, Sofiya Kolusheva5, William F. DeGrado 2 & Ehud Gazit1,6
Peptide-based supramolecular assemblies are a promising class of nanomaterials with
important biomedical applications, specifically in drug delivery and tissue regeneration.
However, the intrinsic antibacterial capabilities of these assemblies have been largely
overlooked. The recent identification of common characteristics shared by antibacterial and
self-assembling peptides provides a paradigm shift towards development of antibacterial
agents. Here we present the antibacterial activity of self-assembled diphenylalanine, which
emerges as the minimal model for antibacterial supramolecular polymers. The diphenylala-
nine nano-assemblies completely inhibit bacterial growth, trigger upregulation of stress-
response regulons, induce substantial disruption to bacterial morphology, and cause
membrane permeation and depolarization. We demonstrate the specificity of these
membrane interactions and the development of antibacterial materials by integration of the
peptide assemblies into tissue scaffolds. This study provides important insights into the
significance of the interplay between self-assembly and antimicrobial activity and establishes
innovative design principles toward the development of antimicrobial agents and materials.
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Self-assembling molecules, including peptides, proteins,lipids, and nucleic acids, are the central building blocks oflife that allow for the formation of cell membranes, cytos-
keletal structures, and the extracellular matrix1,2. Extensive
studies and mechanistic insights into the biophysical properties of
these assemblies have allowed for the harnessing of the self-
assembly process for various nano- and bio-technological
applications2–5. For biomedical purposes, the development of
self-assembled peptide nano-materials has primarily focused on
the fields of regenerative medicine and drug delivery due mainly
to the advantageous characteristics of these materials such as high
biocompatibility levels, chemical diversity, high loading capacity,
and extended circulation6–10. However, few studies have been
carried out on the actual intrinsic antibacterial activity of peptide-
based nanostructures, with the development of self-assembling
materials with antibacterial capabilities primarily concentrated on
complex non-peptide-based polymers and various biomimetics,
and those based on peptide assemblies have been focused on
relatively long and mainly hydrogel forming moieties6,7.
Peptide self-assembly is naturally utilized for fighting infec-
tions. Organisms from all kingdoms of life, including humans,
produce potent membrane-targeting antimicrobial peptides as
part of their innate immune response11–13. Recent reports have
shown that a growing number of these peptides, including
dermaspetin S9, protegrin-1, and human α-defensin 6, among
many others14–23, as well as bacterially secreted peptides24, are
able to self-assemble and form fibrillar amyloid-like nanos-
tructures that play a role in their innate immune activity. Fur-
thermore, additional members of the immune system, such as the
mitochondrial antiviral signaling protein (MAVS), have been
shown to undergo conformational changes and form amyloid-like
structures that enable them to carry out their activity25. These
structures closely resemble classical amyloidogenic assemblies,
which are exceptionally stable unbranched, fibrillar, cross β-sheet
quaternary protein, and polypeptide structures26,27 that attain
their stability through noncovalent interactions, including
hydrogen bonds, hydrophobic interactions, and π–π stacking
interactions28. Interestingly, amphipathic antimicrobial peptides
and short amyloid-related peptides share a similar high frequency
of aromatic amino acids that have been suggested to play a role in
the acceleration and stabilization of the amyloidogenic
assemblies28–30. Moreover, classical amyloid proteins and pep-
tides, such as serum amyloid A, β-amyloid, α-synuclein, PrP, and
the islet amyloid polypeptide, have been shown to display anti-
microbial activity in vitro and ex vivo31–38 and induce innate and
adaptive immunity39–43, with β-amyloid and α-synuclein also
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Fig. 1 The diphenylalanine nanostructures hinder E. coli growth and viability and severely damage bacterial morphology. aMorphology of the nanostructures
formed by the studied peptides. Micrographs were obtained via scanning electron microscopy. Scale bar is 10 µm. b Secondary structure of the studied
peptides as obtained by circular dichroism (CD). CD spectra were obtained for both of the peptides diluted in ultra-pure water at 25 °C. c Kinetics of the
inhibition of bacterial growth. The effect of the diphenylalanine nanostructures and controls on bacterial growth was evaluated by turbidity analysis via
absorbance readings at 600 nm of bacteria treated overnight. d Effect of the diphenylalanine nanostructures on bacterial viability. Bacterial viability was
evaluated using the Live/Dead backlight bacterial viability kit. Green fluorescence of the Syto9 probe indicates bacterial cells with an intact membrane, while
red fluorescence of Propidium Iodide (PI) indicates dead bacterial cells. Scale bar is 50 µm. e Evaluation of the effect of the diphenylalanine nanostructures
on bacterial morphology. Micrographs were obtained using a high-resolution scanning electron microscope. Scale bar is 1 µm
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shown to protect against various infections in in vivo models37,38.
Amyloids have also been demonstrated to enable the formation of
transmembrane pores in both anionic and zwitterionic lipid
membranes, in a mechanism similar to that utilized by anti-
microbial peptides for bacterial membrane permeation, suggest-
ing that common principles govern their folding and
functions23,44–47.
In spite of the recent emerging interest in the correlation
between self-assembly and antimicrobial activity, most studies so
far have been limited to naturally occurring and intricate anti-
microbial peptides and amyloid-forming peptides and proteins,
or their relatively complex mimetics, rather than small organic
building blocks. As a result, there is a lack of mechanistic
understanding of the antibacterial activity of peptide self-
assemblies. Thus, there is a genuine need for simpler systems to
systematically elucidate the structure–function relationship using
minimalistic models that lack the complexities of structure and
interpretation of the full-length proteins and peptides, which
could be extensively manipulated. An important step in this
direction was made by Ghadiri and coworkers in their design of
cyclic hexa- and octa-D,L-alpha peptides, which assembled into
tubular structures mimicking the facially amphipathic nature of
natural antimicrobial peptides and displayed antibacterial
activity48.
Here we describe the development and comprehensive char-
acterization of the most minimalistic model of self-assembling
peptide-based antimicrobial nanostructures reported to date.
Interestingly, while classical antimicrobial peptides are usually
cationic and amphipathic, the nanostructures assembled by
diphenylalanine, which is both neutral and exclusively aromatic,
were identified as a minimal self-assembling model, in terms of
amino acid content, with notable antibacterial activity. Given the
differences between canonical antimicrobial peptides and the
diphenylalanine nanostructures, a comprehensive inquiry into the
mechanism of action of the later agents was carried out, providing
important insights into the significance of the interplay between
self-assembly and antimicrobial activity. Furthermore, the mini-
mal nature of this model makes it an attractive platform for the
development of alternative antimicrobial therapeutics due to the
extensive possibilities for its chemical modifications and allows
for further examination of fundamental questions concerning the
mechanism of action of self-assembling antimicrobial peptides.
Results
Inhibition of bacterial growth. In order to identify the shortest
possible peptide that can facilitate antimicrobial activity by
molecular self-assembly, we applied a minimalistic approach
using diphenylalanine, the core recognition module of the
β-amyloid polypeptide49, and one of the most prominently stu-
died self-assembling and nanostructure forming bioorganic
building blocks50. In order to gain a better understanding of the
significance of self-assembly to antibacterial activity, assembled
diphenylalanine (FF), as well as diglycine (GG), a dipeptide that
does not self-assemble, and non-assembled diphenylalanine,
which consists of diphenylalanine at sub-critical concentrations
(bellow 0.76 mg/ml51), were examined. E. coli was chosen as a
model organism for the analysis, as alongside the well-established
laboratory protocols for its handling, it is the pathogenic agent in
some of the most common worldwide infections and has devel-
oped widespread resistance to last-line classical antibiotics. Fur-
thermore, the transcriptional response to antimicrobial peptide
1200 40,000
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 (A
U)
35,000
30,000
25,000
20,000
15,000
10,000
5000
0
0
50
45
40
35
30
25
%
 F
CR
20
15
10
5
0
Control FF
333 µg/ml
GG
333 µg/ml
10,000 20,000 30,000
Time (s)
40,000 50,000
Control
FF 250 µg/ml
GG 250 µg/ml
Control
FF 333 µg/ml
GG 333 µg/ml
Control
FF 250 µg/ml
GG 250 µg/ml
1000
800
600
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 (A
U)
400
200
0
450
30
25
20
15
%
 F
CR
10
5
0
0 5 10 15
Time (min)
20 25 30
470 490 510 530
Wavelength (nm)
550 570 590
a b
c d
Fig. 2 The diphenylalanine nanostructures cause outer and inner membrane perturbations in E. coli and interact with model membrane systems. a Outer
membrane permeation by the diphenylalanine nanostructures. Outer membrane permeation was determined using the ANS sulfonic amine fluorescent
probe that displays enhanced fluorescence upon exposure of hydrophobic regions. b Cytoplasmic membrane depolarization by the diphenylalanine
nanostructures. The cytoplasmic membrane depolarization activities were determined using the membrane potential sensitive dye DiSC3(5). c, d The
diphenylalanine nanostructures interact with model phospholipid membrane systems. Membrane interactions of each compound were determined via
measurements of the color transitions induced upon interaction of the compounds with DMPE/DMPG/PDA (1:1:3) vesicles. c Kinetics of the initial
membrane interaction of the diphenylalanine nanostructures. d Interaction of the diphenylalanine nanostructures with the model membrane systems after
incubation for 24 h
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treatment and membrane disruption is well known for this
organism52,53, allowing us to probe the mechanism of action of
the studied compounds and to compare it to that of known
antimicrobial peptides. The strain utilized in this study is E. coli
ATCC 25922, a clinical isolate widely used for testing the sus-
ceptibility of bacteria to antibiotics and antimicrobial peptides.
Although not considered a pathogenic strain, it is a widely
acceptable model for the pathogenic E. coli O-strain human
pathogens.
Lyophilized powders of each peptide were heat treated to allow
them to reach their monomeric state and were then cooled down
gradually to room temperature overnight. Biophysical analysis
was carried out using circular dichroism (CD) spectroscopy and
scanning electron microscopy (SEM). The formation of
unbranched nanotubes was observed for FF, whereas GG did
not form structures of any kind and did not present a CD signal
correlated with secondary structure formation (Fig. 1a, b).
In order to evaluate their antibacterial effects, the peptide
samples were added to an E. coli culture, and the antimicrobial
activity of each compound was evaluated via minimum inhibitory
concentration (MIC) analysis, as well as by kinetic growth
inhibition analysis (Fig. 1c; Supplementary Fig. 1). FF exhibited
significant activity toward E. coli, as overnight incubation at 125
µg/ml completely inhibited bacterial growth, with a reduction of
7.1 log (10) CFU/ml (Fig. 1c; Supplementary Fig. 1). In contrast,
GG did not affect bacterial growth at this concentration, nor at
any concentration up to 250 µg/ml (Fig. 1c), and the non-
assembled diphenylalanine samples inhibited bacterial growth by
15–20% (Fig. 1c). Furthermore, in order to assess the spectrum of
the antimicrobial activity of FF, MIC analyses were carried on an
additional Gram-negative bacterium, R. radiobacter, and two
Gram-positive bacteria, S. epidermidis and L. monocytogenes. The
MIC of FF was found to be 250 µg/ml for R. radiobacter and S.
epidermidis and 125 µg/ml for L. monocytogenes (Supplementary
Table 1). At these concentrations, there was a 7.3, 6.5, and 7.1 log
reduction of bacteria, respectively (Supplementary Table 1).
Overall, the activity of the FF nanostructures appears to be broad-
spectrum in nature. To directly assess bacterial viability, the
treated and control bacteria were subjected to Live/Dead viability
analysis at three time points (Th= 0, 1, 24) (Fig. 1d). After 1 h of
treatment with FF, significant bacterial cell death could be
observed and no living bacterial cells were identified. This
continued for 24 h, while GG did not affect bacterial viability
(Fig. 1d).
Inducement of significant damage to bacterial morphology.
The effect of FF and GG treatment on bacterial morphology was
studied following treatment with each of the compounds using
electron microscopy. Numerous nicks and tears were evident in
the cell membrane of the FF treated bacteria (Fig. 1e). Membrane
fusing, clumping, and disintegration were also abundant in these
bacteria, which appeared deflated (Fig. 1e). Cellular debris as well
as lysis of the cells were also evident (Fig. 1e), while the mor-
phology of bacteria treated with GG resembled that of untreated
control bacteria, with no nicks, tears, or membrane disintegration
and clumping observed (Fig. 1e).
Interaction with model membrane systems. The abundant
perturbations and severe morphology disruption caused by FF
treatment point to the bacterial membrane as the main target of
the diphenylalanine nanostructures. Therefore, we evaluated their
ability to induce membrane permeation and depolarization and
directly interact with model membrane systems, subsequently
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Fig. 3 The effect of diphenylalanine nanostructure treatment on the bacterial stress response and their proposed mechanism of action. a Treatment with
diphenylalanine nanostructures causes upregulation of cellular stress-related genes. E. coli bacteria were transformed with plasmids containing each of the
six evaluated genes fused to mCherry and the level of fluorescent signal of mCherry, which correlates to the level of expression of the corresponding gene,
was measured following the indicated treatments. b Model of the proposed mechanism of action of the diphenylalanine nanostructures on Gram-negative
bacteria. The interaction of the diphenylalanine nanostructures with the bacterial membrane causes outer membrane permeation and inner membrane
depolarization, resulting in severe changes to membrane morphology, such as the appearance of nicks and tears, leading to bacterial growth inhibition and
cell death
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shedding light on their mode of action. Following treatment with
FF, significant outer membrane permeation was observed by
monitoring the change in the fluorescent properties of the 8-
anilino-1-naphthalenesulfonic acid (ANS) dye, a probe which
displays increased fluorescence upon binding to hydrophobic
membrane regions (Fig. 2a). Furthermore, rapid inner membrane
depolarization was observed in samples treated with FF, as
indicated by the rapid increase of the fluorescence intensity of the
3,3′-dipropylthiadicarbocyanine iodide (diSC3(5)) lipophilic
potentiometric probe (Fig. 2b). Next, we evaluated the propensity
of the studied compounds to associate with synthetic phospho-
lipid groups present in bacterial membranes by utilizing a model
membrane system54,55 comprising of phosphatidylethanolamine
(PE) and phosphatidylglycerol (PG) liposomes. The interaction of
FF with this system was rapid and continued to grow two-fold
over 30 min and four-fold over night (Fig. 2c, d). The kinetics of
both outer membrane permeation and inner membrane depo-
larization by FF, as well as the interaction with model membrane
systems, match the kinetics of bacterial cell death observed using
the Live/Dead analysis (Fig. 1d), suggesting that the bacterial cell
death was associated with permeation and depolarization of the
outer and inner membranes, respectively. In contrast, GG did not
cause permeation or depolarization of the bacterial membrane
and did not display any interaction with the model membrane
system (Fig. 2).
Upregulation of stress response-associated genes. In order to
gain further insight into the mechanism of action of the diphe-
nylalanine nanostructures, we evaluated the response of bacteria
to sub-lethal concentrations of these agents as this type of analysis
has been shown to be beneficial to the understanding of the
mechanism by which bacteria perceive and react to physiological
perturbations caused by antibacterial treatment52,53. We eval-
uated the effect of FF treatment on the activation of bacterial
responses implicated in sensing cell envelope stress, including the
rcsCB, phoQP, cpxAR, baeSR, and kdpDE two-component sys-
tems, as well as the marA/soxS antibiotic-resistance and super-
oxide stress response regulators. These signal transduction
pathways have been previously shown to be transcriptionally
upregulated following treatment with membrane-active anti-
bacterial agents, such as arylamide foldamers (antimicrobial
peptide mimetics) and polymyxin B (an extensively studied cyclic
antimicrobial peptide)52,53. Reporter strains were constructed by
transforming E. coli with plasmids containing a fluorescent
mCherry reporter under the control of promoter sequences of
each of the evaluated genes: soxS (regulated by marA/soxS), mgtA
(regulated by phoQP), kdp (regulated by KdpDE), spy (regulated
by cpxAR and baeSR), and osmB and bdm (both regulated by
rcsCB). The bacteria were treated with FF, GG, and controls, as
well as with brilacidin (an arylamide foldamer) and polymyxin B,
and the fluorescent signal was measured over time to assay the
upregulation of each stress response pathway. The signal detected
following FF treatment increased over 1.6-fold for each of
the studied genes, while GG did not trigger overexpression of
these genes (Fig. 3a). The most significant upregulation caused
by FF (2.3-fold) was observed for osmB and bdm, two genes that
are part of the rcsCB system, which has been previously shown to
be induced by treatments that cause outer-membrane perturba-
tion and by changes in osmoregulation56. In most cases, the
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Fig. 4 The diphenylalanine nanostructures are non-hemolytic and non-cytotoxic toward human cell lines. a, bMTT cell viability analysis. The cytotoxicity of
the diphenylalanine nanostructures toward two human cell lines was evaluated by the MTT assay using the NAD(P)H-dependent Tetrazolium dye
following over-night treatment with the indicated compounds. a HEK 293 embryonic kidney cell line. b HaCaT keratinocyte cell line. c, d Hemolysis
analysis. The hemolytic activity of the diphenylalanine nanostructures was assessed by incubating defibrinated sheep blood with the compounds and
calculation of the subsequent hemolysis from absorbance readings at 451 and 405 nm. The percentage of non-disrupted blood cells is presented c, as well
as the treated pelleted erythrocytes d
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response to FF was comparable to that of brilacidin and poly-
myxin B, much larger and more complex antibacterial agents,
that are both known to strongly interact with Gram-negative
bacterial membranes52,53. Taken together, these results point to
the bacterial membrane as the main target of FF and support our
findings that FF causes membrane permeation and depolarization
as indicated by the diSC3(5) and ANS assays, as well as the
interaction of FF with model membrane systems and our obser-
vation of the severe effect of FF treatment on bacterial
morphology.
Biocompatibility and specificity. Next, the biocompatibility and
specificity of the observed membrane interactions to bacterial cell
membranes was examined by evaluation of the cytotoxicity of the
diphenylalanine nanostructures towards human cell lines, as well
as their hemolytic activity. Following treatment with the studied
compounds, the viability of both the HEK293 kidney cell line and
the HaCaT keratinocyte cell line was assessed via the MTT based
cell viability assay. All compounds exhibited remarkable bio-
compatibility, as >95% of the cells were viable following treat-
ment with 250 µg/ml of FF, a concentration twice as high as the
minimum inhibitory concentration against E. coli (Fig. 4a, b).
Hemolytic activity was evaluated by spectroscopic measurements
of the amount of hemoglobin released from red blood cells fol-
lowing treatment with FF and controls. After incubation with 250
µg/ml of FF, over 98% of red blood cells remained intact and
undisrupted (Fig. 4c, d). These results demonstrate that the FF
toxicity is not a general phenomenon, but rather specific, toward
prokaryotic cells.
Conference of antibacterial activity to tissue scaffolds. To
examine the potential use of the diphenylalanine nanostructures
as antimicrobial conferring agents in tissue scaffolds, FF was
incorporated into agar-gelatin films, which have been previously
shown to be safe to eukaryotic cells and do not possess inherent
antimicrobial properties (Fig. 5a). Following synthesis and
incorporation of the nanostructures into the matrices, we assessed
the antibacterial activity of these hybrid films. As verified by both
light microscopy and Live/Dead analysis, the films infused with
FF exhibited complete inhibition of bacterial growth as compared
to the control films, while normal bacterial growth was observed
on GG-infused films (Fig. 5b). The successful generation of tissue
scaffolds with intrinsic antibacterial capabilities by incorporation
of these antibacterial nanostructures into biocompatible matrices
provides the basis for an alternative approach to the design and
development of enhanced antibacterial biomaterials.
Discussion
The pioneering work of Kumar et al.37 demonstrated the in vivo
protective activity of the 42 amino-acid long β-amyloid poly-
peptide against potentially lethal infections. While it provided
very important insights on the potential physiological role of
amyloids, it is difficult to discern the physicochemical attributes
that govern the antibacterial activity of this amyloidogenic pep-
tide due to its length and complexity. Thus, we turned to
diphenylalanine, the central recognition module of β-amyloid
that was identified as a fundamental self-assembly motif, in order
to gain insights into the significance of the interplay between self-
assembly and antimicrobial activity.
The results of this study demonstrate that the interaction of
diphenylalanine with bacterial membranes results in membrane
permeation and depolarization, induces upregulation of stress
response regulons and causes severe damage to bacterial mor-
phology, thereby inhibiting bacterial growth and inflicting bac-
terial cell death (Fig. 3b). Furthermore, the incorporation of
diphenylalanine into tissue scaffolds introduces antimicrobial
capabilities to these matrices. Interestingly, diglycine was devoid
of any of these activities while non-assembled diphenylalanine
samples, which consisted of the peptide at sub-critical con-
centrations, inhibited bacterial growth by 15–20%. These results
Agar Gelatin
Composite antibacterial tissue scaffold
FF Original film
Control
FF
GG
Syto9 PI
a b
Fig. 5 Development of diphenylalanine nanostructure incorporated composite antibacterial tissue scaffolds. a Model of the composite diphenylalanine
nanostructure incorporated antibacterial tissue scaffolds. b Incorporation of diphenylalanine nanostructures into the agar-gelatin tissue scaffold completely
hinders growth of bacteria on the scaffold. Bacterial growth was evaluated by turbidity and by Live/Dead bacterial viability analyses
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thus underline the significance of self-assembly to the anti-
microbial activity and membrane interacting capabilities of
diphenylalanine and demonstrate that the antibacterial activity of
diphenylalanine cannot be attributed merely to chaperon-like or
other non-specific interactions.
The minimal nature of the diphenylalanine motif makes this
chemical entity both the shortest antimicrobial peptide-based
agent reported thus far and an important platform for the
development of alternative antimicrobial agents and materials,
due to the extensive possibilities for its chemical modifications, its
low cost and high purity. Such modifications may include the
incorporation of basic amino acids, non-natural amino acids, and
additional functional moieties, which have been shown to greatly
improve the potency of short self-assembling antimicrobial
peptide-based agents57–60. As the MIC of this building block is
currently relatively high, these modifications should allow for the
development of more potent diphenylalanine-based antimicrobial
agents. Furthermore, the biophysical and biochemical character-
istic of this building block are also attractive in terms of the
potentially low probability for development of bacterial resis-
tance. While several bacterial strains have developed counter-
measures to limit the efficacy of classical and synthetic
antimicrobial peptides, mainly by electrostatic repulsion and
reduced binding following modification of cell envelope mole-
cules, the hydrophobic and non-cationic nature of diphenylala-
nine would thus make the acquisition of resistance by such
membrane modifications challenging. Taken together, these
attributes and the results presented in this study ratify the sig-
nificance of diphenylalanine as a minimal self-assembling anti-
microbial building block, and serve to instruct the development of
compelling antimicrobial agents and biomedical materials. Fur-
thermore, this work expands on the growing body of evidence
pointing to a functional link between self-assembly and anti-
microbial activity and provides an important platform for the
further investigation of this interplay as well as design principals
towards an alternative approach to the development of anti-
microbial drugs and biomaterials.
Methods
Sample preparation. Lyophilized powders of each of the peptides (Bachem,
Switzerland) were dissolved in ultra-pure water (BioInd, Israel) to a concentration
of 1 mg/ml and heated for 50 min at 90 °C, allowing for the peptides to reach the
monomeric state, and were then allowed to cool gradually to 25 °C over-night. This
treatment allowed for the self-assembly and nanostructure formation of FF but not
for GG. Non-assembled diphenylalanine samples were prepared by dissolving
lyophilized powder of all-L diphenylalnine in ultra-pure water to a concentration of
0.5 mg/ml and heating for 50 min at 90 °C. This concentration is beneath the
critical concentration of diphenylalanine self-assembly in water, thus restricting
self-assembly and nanostructure formation.
High-resolution scanning electron microscopy for peptide samples. Following
nanostructure formation treatment 10 µl of each compound was deposited on a
glass coverslip and dried under ambient conditions overnight. Samples were then
coated with Cr. Micrographs were recorded using a JSM-6700F FE-SEM (JEOL,
Tokyo, Japan) operating at 5 KV.
High-resolution scanning electron microscopy for bacterial samples. Bacterial
samples were centrifuged at 5000 RPM for 5 min, washed thrice in PBS and fixed in
2.5% glutaraldehyde in PBS buffer for 1 h. Samples were then washed thrice in PBS
and fixed in 1% OsO4 in PBS buffer for 1 h, followed by a dehydration series with
ethanol. Samples were then left in absolute ethanol for 30 min and placed onto
glass coverslips, followed by critical point drying and coating with gold. Micro-
graphs were recorded using a JEOL JSM-6700F FE-SEM scanning electron
microscope operating at 10 KV. Micrographs displayed are representative of three
independent experiments conducted.
High-resolution transmitting electron microscopy for peptide samples. FF
nanostructures which were formed at either 1 mg/ml (above their critical con-
centration) or 0.5 mg/ml (under their critical concentration) were both diluted to
0.125 mg/ml and 10 µl of each sample was immediately subjected to high-
resolution transmitting electron microscopy utilizing a Tecnai 12 TWIN TEM
(FEI) transmitting electron microscope. Micrographs were obtained for three
separate repetitions of each dilution and 50 nanostructures were measured for both
their width and length (a total of 150 nanostructures were measured). The results
of this analysis can be found in Supplementary Fig. 2.
CD spectroscopy. CD spectra were collected with a Chirascan spectrometer
(Applied Photophysics, Leatherhead, UK), which was fitted with a Peltier tem-
perature controller fixed at 25 °C, using a rectangular quartz cuvette with an optical
path length of 0.1 mm (Hellma Analytics, Germany). Following nanostructure
formation treatment, samples were diluted to 0.04 mg/ml and data acquisition was
performed in 1 nm increments at a range of 190–260 nm with a spectral bandwidth
of 1.0 nm and 3 s integration time, at the linear range (<1.5) of absorbance. The
spectrum of each sample was collected thrice and averaged. Spectra were baseline
corrected with ultra-pure water (BioInd, Israel) which was collected similarly. Data
processing was done using Pro-Data Viewer software (Applied Photophysics,
Leatherhead, UK).
MIC analysis and kinetic growth inhibition analysis. MICs were determined
using the microdilution assay. Following nanostructure formation treatment all test
compounds were diluted by serial two-fold dilutions in M9 minimal media in
Corning® (3879) 96-well plates (Sigma-Aldrich, Israel). E. coli bacteria (ATCC
25922) were grown overnight in M9 minimal media and diluted 1000-fold in M9
and grown for 5 h at 37 °C. In Corning® (3596) 96-well plates, 75 µl of the serial
two-fold dilutions of each test compound were added to 75 µl of growth medium
containing bacteria (5 × 106 CFU/ml). Bacteria and test compounds were incubated
overnight at 37 °C and kinetic growth inhibition was determined by optical density
measurements (600 nm) using a Biotek Synergy HT microplate reader. Evaluation
of the reduction in CFUs was obtained by plating bacterial samples before and after
overnight treatment on LB-agar plates. Colony-forming units (CFUs) were counted
after overnight incubation at 37 °C. The MIC was considered the lowest peptide
concentration that showed no increase in optical density and no CFU growth
overnight. Kinetic analysis and CFU reduction displayed are representative of three
independent experiments conducted.
Live/Dead staining for the evaluation of the effect of compounds on bacterial
growth. E. coli bacteria (ATCC 25922) were grown overnight in M9 minimal
media and diluted 1000-fold in M9 and grown for 5 h at 37 °C. Following
nanostructure formation treatment 500 µl of each test compound diluted to 0.5 mg/
ml in M9 minimal media was added to 500 µl of growth medium containing the
bacteria (5 × 106 CFU/ml). At each time point (initial incubation, 1 and 24 h)
samples were taken and washed with saline, incubated for 15 min in a solution
containing propidium iodide and Syto9 (L13152 LIVE/DEAD® BacLight™ Bacterial
Viability Kit, Molecular Probes, OR, USA) and washed with saline again. Fluor-
escence emission was detected using an ECLIPSE E600 fluorescent microscope
(Nikon, Japan).
Antimicrobial effect of tissue scaffolds. Following incubation of the scaffolds
with bacteria overnight, scaffolds were washed with saline, incubated for 15 min in
a solution containing propidium iodide and Syto9 (L13152 LIVE/DEAD® Bac-
Light™ Bacterial Viability Kit, Molecular Probes, OR, USA) and washed with saline
again. Fluorescence emission was detected using an ECLIPSE E600 fluorescent
microscope (Nikon, Japan). Results displayed are representative of three inde-
pendent experiments conducted.
Outer membrane permeability assay. Measurements were performed using the
8-anilinonapthalene-1-sulfonic acid (ANS) uptake assay. E. coli bacteria
(ATCC 25922) were grown overnight in M9 minimal media and diluted 1000-fold
in M9 and grown for 5 h at 37 °C until an OD600 of 0.5. Bacteria were then
washed with 10 mM Tris HCl, 150 mM NaCl buffer (pH 7.4) and resuspended in
the same buffer with 10 µM ANS at an OD600 of 0.05. The resuspended bacterial
samples were then equilibrated in black Greiner CELLSTAR® (655090) 96-well
plates for 20 min. Following nanostructure formation treatment test
compounds were then added to the equilibrated bacterial solutions to a
final concentration of 250 µg/ml and the changes in the fluorescence emission
was measured between 450–600 nm with excitation at 380 nm, using a
CLARIOstar® BMG LABTECH microplate reader. 1% TritonX-100 was used as a
positive control. Results displayed are representative of three independent
experiments conducted.
Inner membrane depolarization assay. Measurements were performed with the
lipophilic potentiometric dye 3,3′-dipropylthiadicarbocyanine iodide (diSC3(5)). E.
coli bacteria (ATCC 25922) were grown overnight in M9 minimal media and
diluted 1000-fold in M9 and grown for 5 h at 37 °C until an OD600 of 0.5. Bacteria
were then washed with 5 mM sodium HEPES, 2 mM EDTA buffer (pH 8) and
resuspended in the same buffer at an OD600 of 0.05. The bacterial samples were
then incubated with 0.4 µM diSC3(5) in black Greiner CELLSTAR® (655090) 96-
well plates for 60–90 min, until a stable reduction of fluorescence was achieved.
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Following nanostructure formation treatment test compounds were then added to
the stabilized bacterial solutions to a final concentration of 250 µg/ml and the
changes in the fluorescence signal was monitored continuously using a CLAR-
IOstar® BMG LABTECH microplate reader (excitation, 622 nm; emission,
670 nm). 1% TritonX-100 was used as a positive control. Results displayed are
representative of three independent experiments conducted.
Preparation of vesicles for model membrane system interaction analysis.
Vesicles comprised of DMPE and DMPG lipid components as well as the diace-
tylene monomer 10,12-tricosadiynoic acid (TRCDA) at a ratio of 1:1:3 (DMPE/
DMPG/TRCDA) were dissolved in a 1:1 chloroform/ethanol mixture and were
dried together in vacuo to constant weight. Deionized water was added to a final
concentration of 1 mM, and the samples were then sonicated at 40W at 70 °C for
3 min using a probe sonicator and subsequently cooled to room temperature. The
vesicle solution was stored at 4 °C overnight and then irradiated at 254 nm for 30 s,
which resulted in the appearance of an intense blue color, due to polymerization of
the diacethylene units.
Fluorescence spectroscopy for model membrane system interaction analysis.
Samples were prepared by adding 30 μl of each of the test and control compounds
at 1 mg/ml to 30 μl of the vesicles followed by addition of 30 μl 50 mM Tris-base
buffer (pH 8.0). Fluorescence measurements (excitation, 485 nm; emission,
555 nm) were carried out on a Fluscan Ascent microplate reader at a constant
temperature of 27 °C, using LP filters with normal slits. The background fluores-
cence of the vesicles alone was negligible. The fluorescent chromatic response
(FCR) was calculated according to the following formula: %FCR= [EmI/
Emred]×100%. EmI is the value obtained for the vesicle treated with the test
compounds, and Emred is the value obtained for the vesicles treated with the
positive control (NaOH 1M). Results displayed are representative of three inde-
pendent experiments conducted.
CD spectroscopy for model membrane system interaction analysis.
Following 15-h incubation of the vesicles with the FF samples were diluted
10-fold and CD spectra were collected with a Chirascan spectrometer
(Applied Photophysics, Leatherhead, UK) as described in the above CD
spectroscopy section. The results of this analysis can be found in the
Supplementary Fig. 3.
Evaluation of the upregulation of bacterial stress response genes. Bacterial
cell reporters were used to quantify activation of bacterial stress-response
implicated regulons and two-component systems. Plasmids were constructed
containing a fluorescent mCherry reporter under the control of the promotor
sequences for genes regulated by the following bacterial stress response implicated
two-component systems and regulons: soxS (regulated by marA/soxS), mgtA
(regulated by phoQP), kdp (regulated by KdpDE), spy (regulated by cpxAR and
baeSR) and osmB and bdm (both regulated by rcsCB). Sequences of the plasmid
and reporters used can be found in the Supplementary Methods. Plasmids were
transformed into E. coli bacteria (ATCC 25922) by electro-transformation.
Briefly, 50 μl of ~109 electro-competent cells were placed in 1 mm gap cuvettes
with ~15 ng plasmid, and transformed with standard settings (1.8 kV, 25 uF,
200 Ohm). The cells were recovered with 1 ml LB and incubated at 37 °C for 1 h
with shaking. Transformants were obtained by plating 50 μl of the bacterial solu-
tion onto LB Agar petri dishes supplemented with 100 μg/ml ampicillin, and
picking colonies following overnight incubation. Transformants were then
grown overnight in M9 minimal media supplemented with trace metals and then
diluted 1000-fold and grown to mid log phase. The bacterial cultures were then
diluted to a final OD600 of 0.1 and treated with Polymyxin B at a final
concentration of 0.6 µg/ml, Brilacidin at a final concentration of 1.1 µg/ml and test
compounds following nanostructure formation treatment at a final concentration
of 250 µg/ml, for 7 h. This was followed by measurement of the absorbance of each
sample at 600 nm as well as the reading of mCherry fluorescence at 620 nm
(excitation at 590 nm). The results presented for each gene were calculated by
normalizing the fluorescent signal to OD600 for each sample. The results presented
are the mean of three independent experiments conducted ±the standard error of
the mean.
Cell cytotoxicity experiments. Test compounds and the negative control (PBS)
were dissolved in PBS at 1 mg/ml and heated for 50 min at 90 °C, followed by
gradual cooling of the solution overnight. Samples were then diluted two fold in
DMEM/Nutrient Mixture F12 (Ham’s) (1:1) (Biological Industries) lacking fetal
bovine serum. 1% TritonX-100 in PBS was used as a positive control. 2 × 105 cells/
ml of the HaCat and HEK 293 cell lines were cultured in 96-well tissue microplates
(100 µl per well) and were allowed to adhere overnight at 37 °C. Cells were plated
on only half of the microplate with the other half consisting of growth medium
with and without each of the test compounds. Cell viability was evaluated using the
3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay
following incubation with the test and control compounds overnight at 37 °C.
Briefly, 10 µl of 5 mg/ml MTT dissolved in PBS was added to each well and
incubated for 4 h at 37 °C. This was followed by the addition of 100 µl of the
extraction buffer [20% SDS dissolved in a solution of 50% dimethylformamide and
50% DDW (pH 4.7)] to each well, and incubation at 37 °C for 30 min. The resulting
color intensity was then measured using a microplate reader at 570 nm. The results
presented are the mean of three independent experiments conducted ± the stan-
dard error of the mean.
Measurement of hemolytic activity. The hemolytic activity of the compounds
was measured as the amount of hemoglobin released by the lysis of erythrocytes.
Briefly, 1 ml of sheep blood was centrifuged at 1000×g for 5 min at 4 °C. The
erythrocytes obtained were washed with three times with PBS (pH 7.2) and
resuspended in PBS. Samples of 100 µl of the erythrocyte solution were incubated
for 2 h in 96-well plates with each of the test compounds following nanostructure
formation treatment in PBS at a final concentration of 250 µg/ml. Intact ery-
throcytes were pelleted by centrifugation at 1000×g for 5 min at 4 °C and the
supernatant was transferred to a new 96-well plate. The release of hemoglobin was
monitored by measuring the absorbance at 451 and 405 nm. The negative
control was PBS treated in the same manner as the test compounds and
the positive control was 1% TritonX-100. The results presented are the
mean of three independent experiments conducted ± the standard error of t
he mean.
Preparation of nanostructure incorporated agar-gelatin gel films. A
mixture of (2 wt%) Agar, (1 wt%) gelatin, and (4 wt%) LB was taken and dissolved
in PBS (pH 7.4). Following nanostructure formation treatment, samples of
each compound were added to this homogeneous mixture to achieve a final
concentration of 750 µg/ml sample, 1 wt% agar, 0.5 wt% gelatin, and 2 wt% LB.
Glutaraldehyde (0.15 wt%) was added to the mixture to achieve cross-linking
of the components in solution and 1 ml of the solution was poured into 24-well
plates and allowed to rest overnight. The plates were then placed in an incubator
heated at 60 °C for 10 h to allow for the formation of the films. To these, 0.1 mM
glycine was added to ensure the blocking of the excess glutaraldehyde and the films
were washed with excess water and PBS to remove the unreacted glycine and
neutralize the surface. The films were then dried and sterilized using UV
irradiation.
Antibacterial activity of agar-gelatin films. E. coli bacteria (ATCC 25922) at an
OD600 of 0.01 were plated onto the films that were allowed to swell in PBS (7.4) and
allowed to grow overnight at 37 °C. Bacterial growth was evaluated by turbidity as
well Live/Dead bacterial viability analysis. Results displayed are representative of
three independent experiments conducted.
Data availability. The authors declare that all of the data supporting the findings
of this study are available within the article and its Supplementary Information
files.
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